Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00174408
Status:
COMPLETED
Last Update Posted:
2007-05-03
First Post:
2005-09-12
Brief Title:
Treatment Of Children With Short Stature At An Age Of 3-7 Years Who Were Born Small For Gestational Age
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
Growth Hormone Treatment in Short Children Born Small for Date Genotonorm
Status:
COMPLETED
Status Verified Date:
2007-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary objective is to evaluate if Genotonorm Genotropin increases linear growth in short children born SGA Safety of the drug is a main objective as well The growth promoting effect of two different dosages is compared The effect of long-term treatment on final height is evaluated according to several amendments
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| A6281048 | None | None | None |